Topic Archives: Exelixis (EXEL)

Comments

  • $PTLA Names Scott Garland President and CEO effective October 8. Formerly Relypsa president and $EXEL CCO https://twitt...

  • An excellent exegesis of excecrable Navellierian exaggeration. I also owned it way back then, and after losing some mone...

  • $MOTELY Fool's top 4 BIO Pics for 2018. Just got a teaser ad for the MF Explorer investment newsletter. They are nomin...

  • I bought $EXEL a few years ago for $11 and change left it alone unil they had a viable product, just sold it when it hit...

  • Some of the companies at the Cantor Fitzgerald Conference this week. Many are also presenting at the Landenburg Thalmann...

  • $ AFMD long From Briefing.com Exelixis (EXEL) initiated with Buy and $33 tgt, Affimed Therapeutics (AFMD) with Buy...

  • $EXEL Doc, thanks for your summation. If you expect failure in the HCC trial that's reason enough for me not to pull th...

  • I'll have a crack at it. It's hard to justify covering, and logging research hours poking into, companies where we see n...

  • $EXEL,$BMY Exelixis and Bristol-Myers are two companies that have gotten relatively scant attention here over the years...

  • $AUPH: My hometown is Melbourne, maybe I should go on a reconnaissance mission as an attaché-for the Gummune. Do you ne...

  • Ophad Hammer blog on $ESPR, $TRVN,$EXEL, $ARGL. Very long ESPR, long EXEL http://www.orf-blog.com/biotech-portfolio-u...

  • $EXEL #RCC $EXEL and Takeda Enter into Exclusive Licensing Agreement to Commercialize and Develop Novel Cancer Thera...

  • Below is an interesting blog article - another affirmation and salutation to Dr. KSS's biotech vision: "2016 Biotech ...

  • Exelixis (EXEL) Cabozantinib bests Sunitinib for mRCC (kidney cancers) . http://www.onclive.com/conference-coverage/e...

  • Exelixis, Ipsen Say European Commission Approves Kidney Cancer Drug 8:17 am ET (Dow Jones)...

  • $EXEL Don't want to steal your time - but do you have a quick opinion about exelixis and its recent mighty run? Haven...

  • $EXEL - From SA: http://seekingalpha.com/news/3187291-exelixis-cabometyx-superior-novartis-afinitor-extending-survival-k...

  • Thank you for the information. I do not own any $EXEL now, but did, and was wondering if would be a good repurchase. I...

  • Someone was asking about Exelixis in the context of its pursuing approval for cabozantinib for renal cell cancer. Keep i...

  • This data will probably move Exelixis (EXEL) Monday morning. http://www.nejm.org/doi/full/10.1056/NEJMoa1408758?af%3DR%...

  • I am a mite concerned here for Exelixis longs. Let's keep in mind: the phase 3 cabozantinib trial has not yet finished. ...

  • $EXEL My questions are How much would Cabozantinib add to the bottom line per share given that Novartis is in this ...

  • Feuerstein thoughts on Exelixis and Puma Bio upcoming catalysts. http://www.thestreet.com/story/13199783/1/biotech-stoc...

  • Mr Hall: I am not a drive-by coin-op when-the-urge-hits-you looker up of information on stocks for people. The etiquette...

  • Hi Dr. KSS, just wanted to know if you had an opinion on EXEL? ASCO Reaffirms Why I'm Holding Exelixis By Investope...

  • Need some help on these tickers, they look interesting to me or other readers. Please volunteer if you are able to pick...

  • XBI HOLDINGS volume order Symbol Description Percent of Net Assets DYAX Dyax Corp 1.75% ESPR Esperion Therapeuti...

  • Expect heavy selling pressure on small cap bio in wake of today's $EXEL brouhaha. $EXEL will be down 50 per cent. Probab...

  • Whilst perusing my portfolio to find a share to dump in order to put in a (limit) order for these new recommendations, I...

  • Exelixis also has a phase III trial for a prostate cancer drug, cabozantinib, which they expected to be stopped because ...

  • As requested, I looked at Exelixis. This company is to me like being in an air traffic control tower; the wind is changi...

  • EXELIXIS announces prelim results in trial of Cobimetinib partnered with Roche. - Data from BRIM7, ongoing phas...

  • KennyG, Thanks for the link. That helps explain some of the drop. I wonder how Cabo would have measured up against str...

  • Exelixis, Inc. (EXEL) announced that the Independent Data Monitoring Committee (IDMC) notified the company today that a ...

  • Interim results on Exelixis' Comet trial for CRPC (castration resistant prostate cancer) http://finance.yahoo.com/new...

  • Thanks to all the outstanding contributors to this continually amazing site! I've been overwhelmed by the breadth and de...

  • Extraordinary really that Dr. KSS is willing to share his vast knowledge with us all. I've become an avid reader of this...

  • Wondering as well what Dr. K and others may think of Exelixis. EXEL's primary compound, Cometriq (Cabozantinib), has bee...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info